The Relevance of Assessment of Functional Parameters of Right Ventricle in Patients with Chronic Heart Failure with Preserved Left Ventricle Ejection Fraction (HFpEF) among the International Studies
DOI:
https://doi.org/10.52340/spectri.2024.09.01.08Keywords:
Chronic Heart Failure with Preserved Left Ventricle Ejection Fraction, Right Ventricle, Transthoracic Echocardiography, Right Ventricular Index of Myocardial PerformanceAbstract
Chronic Heart Failure is a complex syndrome that affects at least 6.5 million of adult population in the USA. Left ventricle preserved ejection fraction is met at least in 50% of those 6.5 million of patients. That data has been published by the Center of Heart and Stroke statistics in 2020. Nowadays, we do not possess the similar information about spreading of this disease among the Georgian population. The scientists have paid huge attention to Chronic Heart Failure with Preserved Left Ventricle Ejection for the latest two decades. In accordance with the scientistic literature, preserved left ventricle ejection fraction (HFpEF) is spread at least in 50% of patients suffered from chronic heart failure. The frequency of this condition gradually increases with age, and it is met especially among women. Based on the epidemiological investigations, the number of HFpEF has been expanded from 47% to 57% during 2000 – 2007. Meanwhile, the frequency of HFpEF has been decreased slightly to 52% in 2010. Right ventricle involvement in pathologic process among the patients with chronic heart failure with preserved left ventricle ejection fraction is a frequent and common problem. It always impacts on patients` quality of life as well as on future prognosis and probability of curing from this condition. The pathogenesis, mechanisms, and prognosis of RV dysfunction in patients with HFpEF has not been fully evaluated yet. There are plenty of questions regarding all those aspects. Scientists and investigators especially focus on Left Ventricle while evaluation the patients with chronic heart failure with preserved left ventricle ejection fraction (HFpEF). Although, medical studies have recently uncovered an active involvement of Right Ventricle in this pathological condition that affects the frequency of patients` hospitalization as well as the mortality rate.
Downloads
References
Authors/Task Force Members:, McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. European journal of heart failure. 2022 Jan;24(1):4-131.
Kitzman DW, Higginbotham MB, Cobb FR, Sheikh KH, Sullivan MJ. Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. J Am Coll Cardiol. 1991 Apr;17(5):1065-72.
Maurer MS, Hummel SL. Heart failure with a preserved ejection fraction: what is in a name?. Journal of the American College of Cardiology. 2011 Jul 12;58(3):275-7.
Upadhya B, Kitzman DW. Heart failure with preserved ejection fraction: new approaches to diagnosis and management. Clinical cardiology. 2020 Feb;43(2):145-55.
Lam CS, Donal E, Kraigher‐Krainer E, Vasan RS. Epidemiology and clinical course of heart failure with preserved ejection fraction. European journal of heart failure. 2011 Jan;13(1):18-28.
Nair N. Epidemiology and pathogenesis of heart failure with preserved ejection fraction. Reviews in cardiovascular medicine. 2020 Dec 30;21(4):531-40.
Upadhya B, Kitzman DW. Heart failure with preserved ejection fraction: new approaches to diagnosis and management. Clinical cardiology. 2020 Feb;43(2):145-55.
Obokata M, Reddy YNV, Melenovsky V, Pislaru S, Borlaug BA. Deterioration in right ventricular structure and function over time in patients with heart failure and preserved ejection fraction. Eur Heart J. 2019 Feb 21;40(8):689-697.
Melenovsky V, Hwang SJ, Lin G, Redfield MM, Borlaug BA. Right heart dysfunction in heart failure with preserved ejection fraction. Eur Heart J. 2014 Dec 21;35(48):3452-62. doi: 10.1093/eurheartj/ehu193. Epub 2014 May 29.
Özlek B, Özlek E, Tekinalp M, Kahraman S, Zencirkiran Agus H, Başaran Ö, Kaya BC, Rencüzoğulları İ, Mert KU, Çakır O, Ösken A. Comparison of clinical characteristics of patients with heart failure and preserved ejection fraction with atrial fibrillation versus sinus rhythm: Insights from the APOLLON registry. Turk Kardiyol Dern Ars. 2020 Apr 1;48(3):234-45.
Lewis GA, Schelbert EB, Williams SG, Cunnington C, Ahmed F, McDonagh TA, Miller CA. Biological Phenotypes of Heart Failure With Preserved Ejection Fraction. J Am Coll Cardiol. 2017 Oct 24;70(17):2186-2200.
Packer M. Should B-type natriuretic peptide be measured routinely to guide the diagnosis and management of chronic heart failure? Circulation. 2003 Dec 16;108(24):2950-3.
Packer M. Can brain natriuretic peptide be used to guide the management of patients with heart failure and a preserved ejection fraction? The wrong way to identify new treatments for a nonexistent disease. Circ Heart Fail. 2011 Sep;4(5):538-40.
Shah AM, Cikes M, Prasad N, Li G, Getchevski S, Claggett B, Rizkala A, Lukashevich I, O'Meara E, Ryan JJ, Shah SJ, Mullens W, Zile MR, Lam CSP, McMurray JJV, Solomon SD; PARAGON-HF Investigators. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction. J Am Coll Cardiol. 2019 Dec 10;74(23):2858-2873.
Bleasdale RA, Frenneaux MP. Prognostic importance of right ventricular dysfunction. Heart. 2002 Oct;88(4):323.
Gorter TM, Hoendermis ES, van Veldhuisen DJ, Voors AA, Lam CS, Geelhoed B, Willems TP, van Melle JP. Right ventricular dysfunction in heart failure with preserved ejection fraction: a systematic review and meta‐analysis. European journal of heart failure. 2016 Dec;18(12):1472-87.
Demirkol S, Ünlü M, Arslan Z, Baysan O, Balta Ş, Kurt İH, Küçük U, Çelik T. Assessment of right ventricular systolic function with dP/dt in healthy subjects: an observational study. Anatolian Journal of Cardiology/Anadolu Kardiyoloji Dergisi. 2013 Mar 1;13(2).
Lewis GA, Schelbert EB, Williams SG, Cunnington C, Ahmed F, McDonagh TA, Miller CA. Biological Phenotypes of Heart Failure With Preserved Ejection Fraction. J Am Coll Cardiol. 2017 Oct 24;70(17):2186-2200.
Mostafa S. Assessment of right ventricular systolic function in heart failure with preserved, reduced and mid-range ejection fraction. Indian Heart J. 2019 Sep-Oct;71(5):406-411.
Tello K, Wan J, Dalmer A, Vanderpool R, Ghofrani HA, Naeije R, Roller F, Mohajerani E, Seeger W, Herberg U, Sommer N. Validation of the tricuspid annular plane systolic excursion/systolic pulmonary artery pressure ratio for the assessment of right ventricular-arterial coupling in severe pulmonary hypertension. Circulation: Cardiovascular Imaging. 2019 Sep;12(9):e009047.
Hussain I, Mohammed SF, Forfia PR, Lewis GD, Borlaug BA, Gallup DS, Redfield MM. Impaired Right Ventricular-Pulmonary Arterial Coupling and Effect of Sildenafil in Heart Failure With Preserved Ejection Fraction: An Ancillary Analysis From the Phosphodiesterase-5 Inhibition to Improve Clinical Status And Exercise Capacity in Diastolic Heart Failure (RELAX) Trial. Circ Heart Fail. 2016 Apr;9(4):e002729.
Naseem M, Alkassas A, Alaarag A. Tricuspid annular plane systolic excursion/pulmonary arterial systolic pressure ratio as a predictor of in-hospital mortality for acute heart failure. BMC Cardiovascular Disorders. 2022 Sep 17;22(1):414.
https://www.cardioserv.net/rv-function-rimp
Nashmil Hashemi, Lars-Åke Brodin, Anders Hedman, Bassem A Samad, Mahbubul Alam, Improved right ventricular index of myocardial performance in the assessment of right ventricular function after coronary artery bypass grafting, Interactive CardioVascular and Thoracic Surgery, Volume 26, Issue 5, May 2018, Pages 798–804.
Cianciulli TF, Saccheri MC, Papantoniou A, Méndez RJ, Gagliardi JA, Prado NG, Riarte AR, Morita LA, Clérici JE, Lax JA. Use of tissue doppler imaging for the early detection of myocardial dysfunction in patients with the indeterminate form of Chagas disease. Rev Soc Bras Med Trop. 2020 Feb 21;53:e20190457. doi: 10.1590/0037-8682-0457-2019.
Shmueli H, Steinvil A, Aviram G, Moaad S, Sharon A, Bendet A, Biner S, Shacham Y, Sherez J, Megidish R, Hasin Y, Elazar E, Letourneau-Shesaf S, Keren G, Berliner S, Topilsky Y. Re-Appraisal of Echocardiographic Assessment in Patients with Pulmonary Embolism: Prospective Blinded Long-Term Follow-Up. Isr Med Assoc J. 2020 Nov;11(22):688-695.
Hayabuchi Y, Homma Y, Kagami S. A novel index equivalent to the myocardial performance index for right ventricular functional assessment in children and adolescent patients. Scientific Reports. 2019 Dec 27;9(1):19975.
Dursunoğlu N, Dursunoğlu D, Kiliç M. Impact of obstructive sleep apnea on right ventricular global function: sleep apnea and myocardial performance index. Respiration. 2005 May-Jun;72(3):278-84.
Grapsa I, Pavlopoulos H, Dawson D, Gibbs JS, Nihoyannopoulos PE. Retrospective study of pulmonary hypertensive patients: is right ventricular myocardial performance index a vital prognostic factor. Hellenic J Cardiol. 2007 May 1;48(3):152-60.
Vizzardi E, D’Aloia A, Bordonali T, Bugatti S, Piovanelli B, Bonadei I, Quinzani F, Rovetta R, Vaccari A, Curnis A, Dei Cas L. Long‐term prognostic value of the right ventricular myocardial performance index compared to other indexes of right ventricular function in patients with moderate chronic heart failure. Echocardiography. 2012 Aug;29(7):773-8.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
